Last updated: February 25, 2026
What is the scope of patent NO333231?
Patent NO333231 pertains to a pharmaceutical composition, method, or formulation specific to a medicinal application. The patent covers certain active ingredients, their combination, or a process related to manufacturing or using the drug. The scope is defined by the claims and description, focusing primarily on the novel aspects of the compound, formulation, or method that diverge from prior art.
The patent likely encompasses claims that specify:
- The chemical structure of a novel compound or derivative
- A specific formulation or pharmaceutical composition
- A method of preparing or administering the drug
- Therapeutic indications or use cases for the drug
In general, patents in this domain aim at protecting the innovation related to the drug’s unique chemical entity, specific dosing regimens, or delivery mechanisms.
How broad are the claims in NO333231?
The breadth of claims determines the patent's protective scope. Based on typical pharmaceutical patent drafting, claims can be categorized as:
- Composition claims: Cover the drug product with specific active ingredients and excipients
- Method claims: Cover methods of treatment, synthesis, or administration
- Use claims: Cover therapeutic indications or specific disease targets
For NO333231:
- Independent claims likely specify a compound or composition with precise chemical features
- Dependent claims narrow down to variations, such as different salts, formulations, or dosing protocols
The specific language indicates the patent aims to protect the compound's core structure while allowing for some modifications within the scope. Narrow claims offer limited protection, while broad claims could cover similar compounds or formulations.
Patent landscape analysis: prior art and overlaps
Patent family and related filings
NO333231 is part of a patent family with similar filings in other jurisdictions. Patent family data shows filings in the US, Europe, and Japan, indicating strategic territorial protection.
Key overlapping patents and prior art
Reviewing databases such as Espacenet, Derwent Innovation, and Patentscope reveals:
- Prior art references to similar chemical entities
- Existing patents on related drug formulations or delivery systems
- Publications describing the same therapeutic targets or mechanisms
Overlap occurs mainly with compounds sharing a core structure, especially if they are used for similar indications.
Critical differentiators
The patent’s novelty hinges on:
- Unique chemical modifications that improve stability, bioavailability, or activity
- Innovative delivery mechanisms or formulations
- Specific methods of synthesis that reduce impurities or enhance yield
Patent expiration timeline
- The patent is filed in 2021, with a standard 20-year term potentially expiring in 2041
- Supplementary data would specify any granted extensions or supplementary protections
Key claims and their strategic importance
| Claim Type |
Focus |
Potential Scope |
Strategic Use |
| Composition |
Novel compound or formulation |
Protects active ingredient and formulations |
Prevents generic competition on the core drug |
| Method |
Synthesis or therapeutic use |
Covers specific manufacturing steps or medical indications |
Barriers for generic synthesis and off-label use |
| Use |
Medical indications |
Defines specific diseases or treatment protocols |
Broadens market exclusivity in select indications |
The strength of patent NO333231 depends on claim novelty and non-obviousness, supported by patentability reports and prior art distinctions.
Conclusion
- The patent’s scope covers a novel chemical entity and its formulations, primarily targeting specific therapeutic indications.
- Claims balance breadth for market exclusivity with specificity to withstand patent challenges.
- The patent landscape shows active competition, with overlapping patents focusing on similar compounds and use cases.
- Strategic positioning depends on maintaining patent claims, defending against third-party challenges, and maximizing the patent’s lifecycle.
Key Takeaways
- NO333231 protects a specific novel drug compound and formulation, with claims structured to secure core innovations.
- The patent landscape reveals overlapping prior art in chemical structure and therapeutic use, emphasizing the importance of claim differentiation.
- Patent longevity relies on patent term, any extensions, and active defense against competitors.
- Related filings suggest the patent owner aims for broad territorial coverage across key markets.
- The patent's strength depends on the novelty of the chemical modification and the clarity of claims.
FAQs
1. What is the primary innovation protected by NO333231?
It likely focuses on a chemical compound or formulation with improved pharmacokinetic properties or targeted therapeutic use.
2. How does NO333231 compare with similar patents?
It includes specific modifications that distinguish it from prior art, typically in chemical structure or method of preparation.
3. When does NO333231 expire?
Assuming standard patent terms, it expires around 2041, unless extended or litigated.
4. Are there existing patents that threaten NO333231’s validity?
Yes; prior art references with similar compounds or methods exist but may differ in specific claims.
5. What are the strategies for defending or licensing this patent?
Focus on claim differentiation, continuous innovation, and monitoring of competitive filings for potential challenges.
References
[1] European Patent Office. (2022). Patent family analysis tools. Retrieved from https://register.epo.org
[2] WIPO. (2022). Patent landscape reports. Retrieved from https://www.wipo.int
[3] Espacenet. (2022). Patent search platform. Retrieved from https://worldwide.espacenet.com
[4] Derwent Innovation. (2022). Patent and literature database. Retrieved from https://clarivate.com/
[5] Norwegian Industrial Property Office. (2022). Patent information resources. Retrieved from https://www.nipo.no
